“Advanced Wound Care market set to grow to $12bn by 2022” says new Visiongain report

30 August 2018
Pharma

Visiongain has launched a new pharma report Advanced Wound Care Market Forecast 2018-2028: Revenue Prospects by Products for Active Wound Care Dressings (Antimicrobial, Foam, Hydrocolloid, Film, Alginate, Hydrogel, Other), Wound Care Devices (NPWT, Ultrasound, Other) and Wound Care Biologics (Skin Replacement, Collagen-Based, Cell-Based, Other), Applications, End-Users and National Market.

Being the largest and fastest growing segment of the wound care market, the advanced wound care market will witness healthy growth during the forecast period. The increasing prevalence of chronic wounds such as venous ulcers, diabetic ulcers and pressure sores is creating demand for more innovative products. It is estimated that around 89 million wounds occur every year; of these around 30 million are chronic wounds and 15 million are burns. Chronic wound incidences will be boosted by the increase in the global over-65 population and rising diabetes incidence both in emerging and mature economies.

The lead analyst of the report commented "The advanced wound care market is expected to experience considerable growth over the forecast period. The main drivers for the growth include an increasingly ageing population, rising prevalence of diabetes and obesity, and growing patient awareness of available products.

In the case of patients suffering from chronic wounds, wound care has become a necessity in order to reduce the risk of morbidity. The number of patients suffering from all forms of chronic wounds is increasing worldwide at around 8% per year; this increasing incidence provides an avenue for substantial growth in the advanced wound care market over the coming years."

Leading companies featured in the report include Acelity, Coloplast, ConvaTec, Mölnlycke, Organogenesis, Smith & Nephew. Notes for Editors If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100 About Visiongain Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Pharmaceutical Product Information Management System Market Report 2020-2030

Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.

19 October 2020

Read

Visiongain Publishes Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.

12 October 2020

Read

Visiongain Publishes Real-World Evidence (RWE) Solutions Market Report 2020-2030

We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

02 October 2020

Read

Visiongain Publishes mRNA Vaccines Market Report 2021-2031

The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential.

02 October 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever